Related Experiment Video
Updated: Apr 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
Dag Olav Dahle1, Ivar Anders Eide, Anders Åsberg
11 Department of Transplant Medicine, Oslo University Hospital, Oslo, Norway. 2 Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Norway. 3 Norwegian Renal Registry, Oslo University Hospital, Oslo, Norway. 4 Metabolic and Renal Research Group, UiT The Arctic University of Norway, Tromsø, Norway. 5 Oslo Centre for Biostatistics and Epidemiology Research Support Services, Oslo University Hospital, Oslo, Norway. 6 Department of Nephrology, Oslo University Hospital, Oslo, Norway. 7 Insitiute of Clinical Medicine, Medical Faculty, University of Oslo, Oslo, Norway.
Background:
The association between aortic stiffness and all-cause mortality in kidney transplant recipients (KTRs) is uncertain, and aortic stiffness has not yet been incorporated into risk prediction tools.
Methods:
During 2007 to 2012, we measured carotid-femoral pulse wave velocity (PWV; SphygmoCor apparatus) 8 weeks after transplantation. The association between PWV and mortality was assessed in a Cox regression analysis adjusting for seven risk factors from a previously validated model. Internal validation was performed by bootstrap resampling, and discrimination and overfitting evaluated by Harrell's C and the calibration slope.
Results:
Of 1497 KTRs, 1040 (69%) had a valid PWV measurement. During a median follow-up of 4.2 years, 82 patients died. The association between PWV and mortality showed a ceiling effect, and PWV was truncated at 12 m/sec. Each 1 m/sec increase in PWV, up to 12 m/sec, was associated with mortality, hazard ratio (HR) 1.36 (95% CI, 1.14-1.62; P = 0.001). An interquartile range increase (3.8 m/sec) tripled the hazard of mortality, HR, 3.21 (95% CI, 1.63-6.31), similar to the effect of being approximately 20 years older (interquartile range increase (21.6 years); HR, 3.06 [95% CI, 1.87-5.29]). The PWV improved model discrimination with an increase in Harrell's C from 0.76 to 0.78; C difference, 0.024 (95% CI, 0.005-0.043; P = 0.01). Overfitting was moderate with a calibration slope of 0.89, and the final model was adjusted accordingly. A spreadsheet version is presented to estimate expected 5-year survival.
Conclusions:
The PWV is a strong risk factor for mortality in KTRs.
Related Concept Videos
Kidney Transplant I: Introduction
Aortic Regurgitation III: Medical Management
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

